Functional studies performed with FMT in germ-free mice further demonstrated how inoculating mice with the identified bacteria, along with the anti-PD-1 therapy, enhanced the anti-cancer effects and inhibited melanoma growth [59]. The gene discussed is PDCD1; the disease is melanoma.